WITHDRAWN

Randomized Controlled Comparison of Pre-op TLIP vs Intra-op TLIP

Talk to us

Conditions

PainSpine Fusionthoracolumbar interfacial plane blocklumbar spine fusionposterior laminectomy with fusion

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

Single-center, randomized study will enroll 50 subjects who are scheduled for 1-3 level posterior laminectomy \& fusion. Study participants who are eligible for the posterior lumbar laminectomy and fusion procedure will be scheduled and also consented as a part of the study. Participants will be stratified based on age and gender to ensure equal distribution.

Official Title

Randomized Controlled Comparison of Preoperative Ultrasound Guided TLIP Block Versus Intraoperative Non-ultrasound Guided TLIP Block

Quick Facts

Study Start:2024-10-28
Study Completion:2025-10-21
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:WITHDRAWN

Study ID

NCT06154980

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * greater than or equal to 18 years of age on the date of service
  2. * require a 1 to 3 level posterior laminectomy with fusion
  3. * compliant with study requirements and outpatient follow-up
  4. * a daily MME less than 25 MME per day in the per-operative period
  1. * younger than 18 years of age on the date of service
  2. * does not consent to participating in the program or to be refusal to follow-up at 2-3 weeks, 4-6 weeks, and 3 months post-operatively
  3. * requiring revision surgery at the same level for posterior laminectomy with fusion
  4. * a daily MME score \>25 MME/day in the pre-operative period will be excluded
  5. * a positive drug screen for cocaine and/or tetrahydrocannabinol (THC), defined in the standard Corewell Drugs of Abuse Screening as cocaine \> 300 ng/mL and cannabinoid \> 50 ng/mL-any
  6. * ongoing lawsuits, workers compensation, and litigation will be excluded.

Contacts and Locations

Principal Investigator

Daniel Park, MD
PRINCIPAL_INVESTIGATOR
William Beaumont Hospitals

Study Locations (Sites)

William Beaumont Hospital
Royal Oak, Michigan, 48073
United States

Collaborators and Investigators

Sponsor: William Beaumont Hospitals

  • Daniel Park, MD, PRINCIPAL_INVESTIGATOR, William Beaumont Hospitals

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-10-28
Study Completion Date2025-10-21

Study Record Updates

Study Start Date2024-10-28
Study Completion Date2025-10-21

Terms related to this study

Keywords Provided by Researchers

  • thoracolumbar interfacial plane block
  • lumbar spine fusion
  • posterior laminectomy with fusion

Additional Relevant MeSH Terms

  • Pain
  • Spine Fusion